Aurobindo gets FDA approval for propafenone hydrochloride ER capsules
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Aurobindo Receives FDA Approval for propafenone hydrochloride ER capsules USP, 225mg, 325mg, and 425mg. Aurobindo Pharma’s propafenone hydrochloride ER capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), RYTHMOL
